C-UTS7targeted protein degradation, TRIM21 E3 ligase, aggregate-selective degraders
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Patents are split by ownership. Held by the company are assigned to this organization. Field corridor patents are held by others in the same technical area — shown to map the freedom-to-operate landscape, not company-owned IP.
Patents assigned to this organization.
WO2012010855A1 - Intracellular immunity - Google Patents WO2012010855A1 - Intracellular immunity - Google Patents Intracellular immunity Download PDF Info Publication number WO2012010855A1 WO2012010855A1 PCT/GB2011/001116 GB2011001116W WO20…
GB202500902D0 - Identifying molecules the mediate targeted degradation - Google Patents GB202500902D0 - Identifying molecules the mediate targeted degradation - Google Patents Identifying molecules the mediate targeted degradation Info Publ…
Blocking or adjacent IP in the same technical area, owned by third parties. Not affiliated with this organization.
WO2025157177A1 - Selective degradation of multimeric proteins via chemically induced proximity to trim21 - Google Patents WO2025157177A1 - Selective degradation of multimeric proteins via chemically induced proximity to trim21 - Google Pate…
US20230301953A1 - Composition for prevention and treatment of myopathy - Google Patents US20230301953A1 - Composition for prevention and treatment of myopathy - Google Patents Composition for prevention and treatment of myopathy Download PD…